Despite the rapid spread of antibiotic resistance among gonococci worldwide, limited reports are available from Brazilian locations. In the present study, 25 quinolone-resistant Neisseria gonorrhoeae (QRNG) strains isolated in Rio de Janeiro, Brazil, were characterized by phenotypic and molecular methods, including analysis of mutations in the gyrA and parC genes. They represented 16.5% of the N. gonorrhoeae isolates obtained during a survey performed from 2006 to 2010. A trend for increasing resistance to ciprofloxacin was observed in the period investigated. The most prevalent pattern of mutation observed among QRNG isolates, Ser-91 to Phe and Asp-95 to Gly in gyrA and Ser-87 to Arg in parC, was detected in 40% of the isolates exhibiting MICs ranging from 4 to >32 g/ml. Gonorrhea is among the most prevalent sexually transmitted diseases (STDs) throughout the world. The causative agent, Neisseria gonorrhoeae, predominantly infects human urogenital tract, causing cervicitis, urethritis, and rectal infections. In 2003, the incidence of gonococcal infections in Brazil was estimated in 1,54 million of cases, being 657,139 cases in the Southeast region and more than 130,000 cases in Rio de Janeiro state (5). Recently, two studies conducted among men attending STD clinics (1) and among pregnant women (15) in six Brazilian cities revealed prevalences of infection by Neisseria gonorrhoeae of 18.4 and 1.5%, respectively.Since the emergence and increasing occurrence of plasmidmediated high-level or chromosomally mediated low-level resistance to penicillin and/or tetracycline, fluoroquinolones (ciprofloxacin or ofloxacin) or cephalosporins (ceftriaxone and cefixime) constitute the therapeutic regimen recommended by the World Health Organization for treatment of gonococcal infections worldwide (25).However, the emergence of quinolone-resistant N. gonorrhoeae (QRNG) isolates has generated significant concern in several countries (13,26,31). Mechanisms of quinolone resistance in N. gonorrhoeae isolates include point mutations at the "quinolone resistance-determining regions" (QRDRs) of the gyrA and parC genes which code for the enzymes DNA gyrase and topoisomerase IV, respectively, that were the target of this drug, conferring high-level quinolone resistance (13).In Brazil, reports on the antimicrobial susceptibility of N. gonorrhoeae have been sporadically available, and only a few isolates with decreased susceptibility to ciprofloxacin were described (2, 11, 12). In 2007, we detected the occurrence of resistance to ciprofloxacin in 7.7% (4/52) of the N. gonorrhoeae isolates recovered from male urethral specimens or vaginal specimens in Rio de Janeiro, Brazil (A. A. Uehara and S. E. L. Fracalanzza, unpublished data). Simultaneously, a resistance rate of 3.1% was found in strains isolated from patients attending the STD Service of the University of São Paulo teaching hospital, in São Paulo, Brazil (3).The aim of the present study was to characterize ciprofloxacin-resistant N. gonorrhoeae isolates recovered in Rio de Janeiro,...